About Anne Rubin
Form D filings for Perceive Biotherapeutics in 2023 list Anne Rubin as executive officer and director.
Anne Rubin first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Anne Rubin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anne Rubin works with at each company, as listed on that company's latest Form D.
Perceive Biotherapeutics, Inc. · Form D, Jan 13, 2023
WD
Watson Debi
Director
KM
Kirsten Macfarlane
CEO and director
CW
Cameron Wheeler
Director
RO
Randall Olson
Director
RJ
Robert Jackson
Director